In terms of mechanistic insights, classical oncology literature posits that tumor cells can upregulate the expression of PD-L1 through transcription factors such as ATF3, thereby exhausting effector T-cell function and achieving immune evasion [25,26]. This evidence concerns the gene ATF3 and neoplasm.